PENDARVIS DAVID

About PENDARVIS DAVID

David B. Pendarvis is an experienced legal and corporate governance executive, best known for his role as an independent director at WD-40 Company. He was elected to WD-40’s board in 2017, where he has contributed a strong governance, risk oversight, and compliance perspective. His board service has included committee work in audit, compensation, and corporate governance, underscoring a profile centered on internal control, disciplined oversight, and shareholder alignment. Before joining WD-40’s board, Pendarvis built the core of his career at ResMed Inc., a global medical technology company listed in the United States. He joined ResMed in 2002 as global general counsel and became corporate secretary in 2003. From 2005 to 2011, he served as executive vice president of organizational development, and in 2011 he was named chief administrative officer and global general counsel. He remained in that role through 2023 and also served as interim president for EMEA and Japan in 2017. This progression reflects a move from a legal leadership function into broader executive responsibilities spanning governance, organizational leadership, and international operational oversight. Pendarvis’s earlier career in private practice also shaped his executive profile. Prior to ResMed, he was a partner at Gray Cary Ware & Freidenrich and later at Gibson, Dunn & Crutcher, after beginning his career as a law clerk to a United States federal district court judge. That combination of litigation, strategic legal counsel, and board-level governance experience gives him a versatile background well suited to supporting director responsibilities and advising companies operating across complex regulatory and global business environments.